Alexion Pharmaceuticals, Inc. | LinkedIn (original) (raw)

About us

Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally. GL/NP/0116 GL/NP/0095 Community Guidelines: https://bit.ly/39x9gqy

Industry

Biotechnology Research

Company size

1,001-5,000 employees

Headquarters

Boston, Massachusetts

Type

Public Company

Founded

1992

Specialties

Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, and nephrology

Locations

Employees at Alexion Pharmaceuticals, Inc.

Updates

New research from AstraZeneca in Nature Portfolio demonstrates the transformative potential for gene editing to transform outcomes for people living with rare genetic disorders by addressing their underlying causes. The new gene editing tool showed enhanced precision to correct genetic mutations, while reducing off-target effects. This advancement could help accelerate potential new treatments for a range of diseases, including rare conditions—of which 80% are believed to have a genetic cause. Learn more here: http://spr.ly/6045aZ7vf
Hear from our diagnostics team, Banu Sankaran, Tom Defay and Chathuri Daluwatte, PhD, about promising areas of diagnostic innovation that aim to shorten the path to diagnosis. By harnessing these technologies for diagnostics, we are working to bring new hope to people impacted by rare diseases.
To better understand the impact of #RareDisease on patients and their caregivers, we need to look at what life was like before their diagnosis. That’s where Adrian Kielhorn, Senior Director, Health Economics and Outcomes Research, and his team come in. Hear his take on this important research and what makes working in #RareDisease so unique.
More than 90% of #RareDiseases have no approved treatment option. We’re determined to change that. Learn how we’re working tirelessly to deliver on that promise for the millions of rare disease patients worldwide: http://spr.ly/6041WUsFH
For us, patient centricity isn't just a goal—it's our guiding principle. If you’re passionate about improving the lives of people affected by #RareDiseases, we’d love to have you on our team. Apply now: http://spr.ly/6042WUSrg
Amyloid light chain (AL) amyloidosis is the most common form of systemic #Amyloidosis. AL can result in significant organ damage and organ failure that can severely impact quality of life and can ultimately be fatal.
382,841 followers
1mo Edited
Hear from our diagnostics team, Banu Sankaran, Tom Defay and Chathuri Daluwatte, PhD, about promising areas of diagnostic innovation that aim to shorten the path to diagnosis. By harnessing these technologies for diagnostics, we are working to bring new hope to people impacted by rare diseases.
Since 2013, our Blanchardstown, Dublin facility has served as Alexion’s Global Supply Chain and Operations headquarters, enabling us to deliver first-class product to patients around the clock. Watch the video to hear from our Site Lead & Executive Director Maureen Larkin as she shares more about the onsite operations and vibrant team culture there: http://spr.ly/6047WUm21
Get to know Alexion in Ireland

https://www.youtube.com/

We are committed to fostering a culture of continuous learning and development by offering ample opportunities for our people to thrive and progress in their careers. Hear from two of our colleagues, whose careers grew in ways they could never have imagined at Alexion.
What gets our Head of Patient Experience and Insights excited about coming to work at Alexion? The shared sense of purpose. Hear how Wendy Erler’s journey to patient advocacy began right in her own backyard–and how it has led her to become a passionate advocate for patients ever since. #LifeAtAlexion
Life At Alexion: A Shared Sense of Purpose

Alexion Pharmaceuticals, Inc. | LinkedIn (original) (raw)

About us

Locations

Employees at Alexion Pharmaceuticals, Inc.

Updates

https://www.youtube.com/

https://www.youtube.com/

Join now to see what you are missing

Similar pages

Browse jobs

Funding